A startup launches with plans to open up a gene and cell therapy bottleneck

Vector BioMed, a new biotechnology company based in Gaithersburg, Maryland, hopes to help. The company officially launched Tuesday, pitching itself as a solution for gene and cell therapy makers needing to more quickly make their drugs. The company has its own manufacturing capabilities that it claims to be scalable, as well as vectors it’s making in-house and can offer to partners.